SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

GameStop is trending following an unsolicited fifty-six billion dollar acquisition bid for eBay, a move that has sparked intense debate among investors regarding the viability of such a highly leveraged acquisition. Community members are actively split, with some viewing the move as a visionary corporate chess play, while critics, including high-profile investors, have voiced significant concerns over the proposed debt levels and potential share dilution.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as institutional interest remains high, highlighted by the strong performance of Bitwise's XRP ETF and increasing institutional adoption of the XRP Ledger for real-world asset tokenization. Community sentiment is deeply split, with investors actively debating the potential impact of ongoing regulatory developments like the Clarity Act against concerns regarding Ripple's circulating supply and long-term price suppression.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant institutional accumulation as investors position themselves ahead of major clinical readouts, including the upcoming 52-week data for its sonelokimab program. The community is focused on this data and the Goldman Sachs conference, with many speculating that these events could serve as the catalyst for an acquisition or a significant upward repricing.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting intense community attention as retail investors analyze the company's evolving commercial landscape, particularly the data regarding Tonmya prescription trends and insurance access. While sentiment remains polarized due to ongoing dilution concerns and the leadership of CEO Seth Lederman, community discussions are heavily focused on tracking the company's prescription growth as a primary catalyst for potential valuation improvement.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is experiencing significant investor attention driven by speculation surrounding a potential strategic carve-out of its China operations and the company's recent shift toward profitable growth. Community discussion is heavily focused on the stock's low valuation relative to its brand reach, the anticipation of new product launches in the US, and the belief that JAB Holding's increased stake signals a long-term turnaround or acquisition play.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as community members debate whether the assets rapid, leverage-driven ascent is a sustainable momentum play or a dangerous bubble tied to the South Korean semiconductor cycle. Traders are actively tracking shifts in the KOSPI index and local corporate news, weighing the risk of massive overnight swings against the potential for continued gains from the high-bandwidth memory shortage.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI is currently a focal point for investors following the successful securing of a U.S. Navy contract for hypersonic missile development and reaffirmed multi-hundred percent revenue growth guidance. Community discussion remains intensely divided between retail investors betting on a potential short squeeze due to high short interest and long-term supporters focused on the company's pivot into integrated defense manufacturing and autonomous swarm technology.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is under pressure following reports of a smaller-than-anticipated aircraft order from China, prompting intense community debate over whether the selloff is an overreaction to delivery expectations or a sign of deeper operational hurdles. Investors are actively discussing the stock's long-term potential against a backdrop of massive order backlogs and a critical focus on production ramp-up targets.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoin is experiencing a surge in community engagement driven by anticipation surrounding its upcoming project developments and potential integration with the broader OpenAI ecosystem. Investors are actively debating the token's long-term utility in the AI-driven economy while closely monitoring its correlation with Eightco Holdings and broader market sentiment regarding AI-related assets.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is currently trending as community discourse focuses heavily on Bitcoin's broader market volatility and its sensitivity to geopolitical tensions, particularly regarding potential trade impacts in the Strait of Hormuz. Investors remain sharply divided, debating the merits of self-custody versus institutional ETFs while tracking the impact of significant corporate treasury shifts and persistent macro uncertainty on asset prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 Whitehawk Therapeutics Presents RealWorld Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC...

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference PR Newswire MORRISTOWN, N.J., May 28, 2026 MORRISTOWN, N.J., May 28, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc.(Nasdaq...

WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise  

Equity

Whitehawk said it has secured rights from Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs.

Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload

Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload PR Newswire MORRISTOWN, N.J., May 21, 2026 Agreement with Hangzhou DAC Provides Option for Up...

Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit

Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit PR Newswire MORRISTOWN, N.J., May 20, 2026 MORRISTOWN, N.J., May 20, 2026 /PRNewswire/ -- Whitehawk Therapeutics...

Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum PR Newswire MORRISTOWN, N.J...

Chasing the Next Explosive Small-Cap Run

Risk appetite came roaring back and several companies standing out, as market participants rotated heavily into sectors tied to transformative technologies and high-growth macro trends. $TGNT, $QUCY, $AEHL, $TDIC, $WGRX, $ERNA, $SLS, $WHWK

Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing

Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing PR Newswire MORRISTOWN, N.J., May 13, 2026...

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Short Interest Update

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totaling 780,056 shares, a growth of 12.4% from the March 31st total of 693,909 shares. Currently, 3.3% of the shares of the stock are sold...

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 Whitehawk Therapeutics Presents Comprehensive Preclinical Data...

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

WHWKWhitehawk Therapeutics Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WHWK News